Simon Read Insider Trading $RARX Ra Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Simon Read.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Simon Read. Simon Read is Chief Scientific Officer in Ra Pharmaceuticals, Inc. ($RARX).
Simon Read in Ra Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Simon Read: Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 03 2020
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Simon Read in Ra Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 0.00 | 9,166 | 0 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 21.00 | 107,000 | 2,247,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 7.33 | 55,000 | 403,150 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 16.64 | 67,500 | 1,123,200 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 5.60 | 25,000 | 140,000 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 2.87 | 26,422 | 75,831 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | D | 2.87 | 46,434 | 133,266 | 0 | |
| Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | D | 48.00 | 12,595 | 604,560 | 0 | 12.6 K to 0 (-100.00 %) |
| Dec 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 2.87 | 10,000 | 28,700 | 46,142 | |
| Dec 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 47.08 | 10,000 | 470,821 | 6,234 | 16.2 K to 6.2 K (-61.60 %) |
| Dec 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 2.87 | 10,000 | 28,700 | 16,234 | 6.2 K to 16.2 K (+160.41 %) |
| Nov 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 2.87 | 10,000 | 28,700 | 56,142 | |
| Nov 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 46.68 | 10,000 | 466,808 | 6,234 | 16.2 K to 6.2 K (-61.60 %) |
| Nov 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 2.87 | 10,000 | 28,700 | 16,234 | 6.2 K to 16.2 K (+160.41 %) |
| Oct 17 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 2.87 | 10,000 | 28,700 | 66,142 | |
| Oct 17 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 46.87 | 10,000 | 468,726 | 6,234 | 16.2 K to 6.2 K (-61.60 %) |
| Oct 17 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 2.87 | 10,000 | 28,700 | 16,234 | 6.2 K to 16.2 K (+160.41 %) |
| Sep 16 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 2.87 | 10,000 | 28,700 | 76,142 | |
| Sep 16 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 25.41 | 10,000 | 254,050 | 6,234 | 16.2 K to 6.2 K (-61.60 %) |
| Sep 16 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 2.87 | 10,000 | 28,700 | 16,234 | 6.2 K to 16.2 K (+160.41 %) |
| Aug 27 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 2.87 | 10,000 | 28,700 | 86,142 | |
| Aug 27 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 27.77 | 10,000 | 277,703 | 6,234 | 16.2 K to 6.2 K (-61.60 %) |
| Aug 27 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 2.87 | 10,000 | 28,700 | 16,234 | 6.2 K to 16.2 K (+160.41 %) |
| Jul 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 2.87 | 10,000 | 28,700 | 96,142 | |
| Jul 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 32.95 | 10,000 | 329,479 | 6,234 | 16.2 K to 6.2 K (-61.60 %) |
| Jul 18 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 2.87 | 10,000 | 28,700 | 16,234 | 6.2 K to 16.2 K (+160.41 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 2.87 | 10,000 | 28,700 | 106,142 | |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 23.09 | 414 | 9,560 | 6,234 | 6.6 K to 6.2 K (-6.23 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Sell | S | 22.21 | 9,586 | 212,908 | 6,648 | 16.2 K to 6.6 K (-59.05 %) |
| Jun 19 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 2.87 | 10,000 | 28,700 | 16,234 | 6.2 K to 16.2 K (+160.41 %) |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 0.00 | 9,167 | 0 | 18,333 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | A | 21.00 | 107,000 | 2,247,000 | 107,000 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Payment of Exercise | F | 21.00 | 2,933 | 61,593 | 6,234 | 9.2 K to 6.2 K (-32.00 %) |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 0.00 | 9,167 | 0 | 9,167 | 0 to 9.2 K |
| Feb 05 2018 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | A | 0.00 | 27,500 | 0 | 27,500 | |
| Feb 05 2018 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | A | 7.33 | 55,000 | 403,150 | 55,000 |
Page: 1